L eukocyte recruitment from the blood into tissues is mediated by multistep cascades that require the sequential engagement of several distinct surface receptors on leukocytes and endothelial cells (1) (2) (3) . Most adhesion cascades are initiated by one or more members of the selectin family, which mediate initial contact (tethering) and rolling of leukocytes in postcapillary venules (4, 5) . L-selectin (CD62L), a leukocyte surface adhesion molecule, is essential for leukocyte recruitment to many sites of inflammation and for homing of naive lymphocytes to peripheral lymph nodes (6 -9) . This glycoprotein has a distinctive ectodomain consisting of an N-terminal C-type lectin domain, an epidermal growth factor-like domain, and two short consensus repeats. The ectodomain is followed by a single transmembrane (TM) 4 domain and a short (17-aa) C-terminal intracellular (IC) domain (10 -13) .
L-selectin mediates leukocyte tethering and rolling through binding to ligands on vascular endothelial cells in the presence of hydrodynamic shear (6, 7) . It is constitutively expressed on most leukocytes (except a subset of effector/memory cells), including granulocytes, monocytes, and lymphocytes (reviewed in Ref. 4) . The exquisite ability of L-selectin to initiate cell-cell contact in the presence of strong hydrodynamic shear is facilitated by its surface topography (14, 15) ; L-selectin is clustered on the tips of microvillous surface protrusions on neutrophils and lymphocytes (16, 17) . This topography is maintained even when L-selectin cDNA is expressed in cells that are normally devoid of L-selectin (14, 18, 19) . Previous studies have established the importance of microvillous topography for leukocyte tethering and rolling in vitro and in vivo (14, 15) . Transfected lymphoid cells expressing wild-type (WT) L-selectin on microvilli initiated rolling interactions on physiologic ligands in lymph node high endothelial venules much more efficiently than cells that expressed randomly distributed L-selectin ectodomains. In turn, the latter cells rolled more frequently than transfectants expressing L-selectin ectodomains only on the cell body (15) .
It has been proposed that the physiologic presentation of Lselectin clusters on the most distal aspects of the cell surface enhances the molecule's bioavailability during brief collisions between rapidly flowing leukocytes and ligand-bearing endothelial cells (16) . Consistent with this concept, other leukocyte adhesion molecules that initiate adhesion to endothelium under flow are similarly concentrated on microvilli. Besides L-selectin, the two ␣ 4 integrins, ␣ 4 ␤ 7 and ␣ 4 ␤ 1 (20, 21) , the sialomucin P-selectin glycoprotein ligand-1 (22, 23) , and E-selectin ligand-1 (24) are all concentrated on microvilli. In contrast, the hemopoietic isoform of CD44 and the ␤ 2 integrins LFA-1 (␣ L ␤ 2 ) and Mac-1 (␣ M ␤ 2 ) are found predominately on the cell body (14, 20, 25) . Other leukocyte-expressed molecules, such as the murine T cell marker Thy1 and sialyl-Lewis X , are randomly distributed over the entire cell circumference (16, 26) .
When leukocytes become activated, L-selectin is rapidly shed from the cell surface by a zinc-based metalloprotease that cleavesAddition of PMA, which activates the protein kinase C (PKC) pathway, triggers the rapid disappearance of L-selectin from the surface of leukocytes to nearly complete loss of expression within a few minutes (28) . Several observations have established that activation-induced down-regulation of L-selectin is mediated by proteolytic cleavage of the ectodomain: the supernatant of activated leukocytes contains increased levels of a protein that reacts with Abs to epitopes on the ectodomain, but not the IC domain of Lselectin (30) ; conversely, activated neutrophils lose ectodomain epitopes, but maintain a 6-kDa protein fragment that is detected by Abs to the IC domain of L-selectin and is not found in resting leukocytes (30) ; hydroxamate-based inhibitors of zinc metalloproteases block activation-induced L-selectin shedding (34 -36) ; finally, several groups have shown that mutations in the membraneproximal short consensus repeats can reduce or abolish activationinduced shedding of L-selectin ectodomains (30 -33) . Indeed, the cleavage site of L-selectin has been located between Lys 321 and Ser 322 , which are predicted to lie within the first 15 amino acids proximal to the cell membrane (30) .
To date, the protease(s) responsible for L-selectin cleavage (sheddase) from mature leukocytes remain(s) to be identified. One likely sheddase candidate is TNF-␣-converting enzyme (TACE), which has been shown to mediate activation-induced L-selectin shedding from fetal thymocytes (37) . Interestingly, a recent study has shown that TACE has a punctate distribution on the surface of human THP-1 and Jurkat cells (38) . This staining pattern resembles that seen on human leukocytes stained for L-selectin (25) . Thus, we speculated that the extremely fast kinetics of L-selectin shedding could be facilitated by colocalization of the sheddase and its substrate on the tips of microvilli. However, this possibility has not been explored experimentally. Moreover, the extra-and intracellular factors that control sheddase activity are poorly understood. It has been shown that a partial truncation of L-selectin, called L⌬cyto, in which 11 of the 17 predicted cytoplasmic amino acids were deleted, does not affect microvillous presentation or PMA-induced shedding of the ectodomain (19, 31) . In contrast, as mentioned above, replacement of the entire TM/IC region alters L-selectin topography (14) , indicating that critical L-selectin-specific recognition motifs must be contained within the TM domain or the juxtamembrane cytoplasmic stump of the L⌬cyto mutant. Whether these regions are also involved in regulating shedding has been unknown.
One recent study has demonstrated that calmodulin, a calcium regulatory protein, binds directly to the IC domain of L-selectin (39) . When leukocytes were treated with trifluoperazine (TFP) or other calmodulin inhibitors, proteolytic shedding of L-selectin was observed. Thus, it was postulated that calmodulin may regulate the expression of L-selectin by interacting with its IC domain (39) . Calmodulin binding to L-selectin was abrogated upon mutation of either one of two amino acids within the membrane-proximal cytoplasmic region that was not deleted in the L⌬cyto construct (39) . Together, these observations indicate that the C-terminal 11 amino acids of the L-selectin IC domain are not required for shedding, but a role for the remainder of the IC domain or the TM region cannot be excluded. Furthermore, it has not been tested whether shedding is altered by mutations in L-selectin that abolish calmodulin binding.
To clarify the cellular mechanisms of L-selectin shedding, we set out to determine whether the TM/IC fragment of L-selectin plays a role in this process. Using transfectants that expressed fulllength L-selectin ectodomains with different TM/IC domains, we show that despite significant differences in the surface topography of chimeric proteins, all transfected cell lines shed L-selectin efficiently upon activation with PMA or inhibition of calmodulin activity. Scanning immunoelectron microscopy of activated cells revealed distinct changes in the appearance of cell surface protrusions, but the distribution of ectodomains was not significantly altered compared with that of resting cells. Loss of L-selectin ectodomains correlated with the presence of soluble L-selectin (sL-selectin) in culture supernatants, and ectodomain cleavage in WT and mutant transfectants was blocked by a hydroxamate-based protease inhibitor, suggesting that a similar protease(s) cleaves Lselectin regardless of ectodomain distribution or subsurface structures. Thus, although a subtle role for intracellular calmodulin binding to L-selectin was evident, subsurface domains are not required for activation-induced L-selectin shedding from leukocytes.
Materials and Methods

Abs and reagents
The mAb DREG-200 (mouse IgG1), which recognizes an epitope in the ectodomain of human L-selectin (29) , was purified from culture supernatants following standard procedures. CFSE-labeled DREG-200 monovalent Fab were prepared as previously described (6) 
Preparation of cells
We used murine L1-2 pre-B lymphoma cell lines that were stably transfected with human WT L-selectin (40) or with chimeric molecules consisting of the human L-selectin ectodomain linked to the TM/IC segment of CD44 (L/CD44) (14) or the TM/IC segment of CD31 (L/CD31) (15) . In the two chimeric cell lines, the last amino acid (Pro 332 ) of the predicted ectodomain of mature L-selectin was linked to the first amino acid of the predicted TM domains of human CD44H (Trp 269 ) and human CD31 (Gly 602 ), respectively. A parental cell line transfected with the pMRB101 expression vector alone (L1-2 vector ) served as a negative control. All L1-2 transfectants were cultured in six-well tissue culture plates (BD Biosciences, Franklin Lakes, NJ) in RPMI 1640 medium (BioWhittaker, Walkersville, MD) containing standard supplements, 2.5 g/ml mycophenolic acid (Sigma), 125 g/ml xanthine (Sigma), 1ϫ hypoxanthine/thymidine (Life Technologies, Grand Island, NY), and 1.5 mM HEPES (pH 6.5). For experiments, cells were washed and counted, and dead cells were removed, if necessary, by centrifugation over Histopaque 1077 (Sigma). Subsequently, cells were resuspended to 1 ϫ 10 7 cells/ml in the same medium and used within 1 h for experiments.
FACS analysis
Expression of WT and chimeric L-selectin ectodomains on L1-2 cells was assessed before and after activation with PMA. Cell samples (1 ϫ 10 6 /ml) in RPMI 1640 (BioWhittaker) containing 10% FBS (Gemini Bioproducts, Calabasas, CA) and 20 g/ml CFSE-DREG-200 Fab were incubated for 20 min at room temperature or 4°C, washed twice, and analyzed on a FACScan flow cytometer (BD Biosciences). Control experiments showed that incubation with CFSE-DREG-200 Fab (up to 1 h at 37°C) did not alter ectodomain expression on any transfectant used in this study (data not shown). FACS results were expressed as specific mean fluorescence channel number (MFI) of 5000 cells after subtracting the background MFI, which was determined by parallel staining of L1-2 vector cells. For some experiments, specific MFI was converted to mean copy number of WT and chimeric ectodomains on transfectants using a calibrated microbead system (Quantum Simply Cellular, Flow Cytometry Standards, San Juan, Puerto Rico) following the manufacturer's instructions.
Low voltage scanning electron microscopy (LVSEM)
Transfectants were stained with anti-L-selectin ectodomain mAb followed by colloidal gold-conjugated goat anti-mouse IgG and prepared for analysis of surface features and colloidal gold distribution by LVSEM as previously described (14, 17) . WT L-selectin on L1-2 cells has been shown previously to be clustered on the tips of microvilli (14, 17, 18) , whereas L/CD44 is preferentially targeted to the planar cell body (14) , and L/CD31 has a random topography with equivalent expression density on microvilli and the cell body (Ref. 15 and this report). L-selectin ectodomain topography on each nonactivated cell line was confirmed for this study. The same cell populations were also prepared for LVSEM analysis after exposure to PMA (10 Ϫ6 M at 37°C) for 1 and 3 min. Gold particle distribution was determined by analysis of digital images taken with a Hitachi S-900 LVSEM (Hitachi, Tokyo, Japan). Secondary electrons were collected by an Everhart-Thornley detector, and an Autrata modified YAG detector was used for backscatter electron detection. Gold particle distribution was assessed by blinded observers on individual cells photographed at 60,000-fold magnification based on the following criteria: microvilli were classified as any identifiable projection emanating from the cell surface; to maintain uniform criteria for comparison of differently treated cell samples, other surface protrusions, such as ridges, or ruffles, which were frequently seen on cells after activation with PMA, were also classified as microvilli; microvilli were further divided into upper and lower halves based on visual estimation of the midpoint between microvillous tip and base. Regions that were not part of microvilli were defined as cell body associated.
PMA-induced activation of L1-2 transfectants
For dose-response studies, cell samples were pretreated at 4°C with 20 g/ml CFSE DREG-200 Fab. A stock of 1 mM PMA was serially diluted in RPMI 1640 with 10% FBS, and 10 l of each dilution was pipetted into 96-well round-bottom tissue culture plates. Ninety microliters of prewarmed (37°C) transfectant suspension at 5 ϫ 10 6 cell/ml was then added to each well. Samples were incubated for 15 min at 37°C, washed, fixed with 1% paraformaldehyde, and analyzed on a FACScan flow cytometer as described above.
For kinetic studies, transfectants were incubated at 37°C in the presence of 20 g/ml CFSE-DREG-200 Fab. PMA was added to a final concentration of 10 Ϫ6 M. Aliquots of cells were taken three times before and at nine consecutive time points after activation. Further activation of sampled cells was stopped by immediate transfer into an equal volume of ice-cold RPMI 1640 containing 10% FBS and 2% paraformaldehyde. Fixed samples were analyzed by flow cytometry as described above.
sL-selectin ELISA
Ninety-six-well, flat-bottom microtitration plates (Linbro/Titer-Tek, ICN Pharmacueticals, Costa Mesa, CA) were coated with 10 g/ml mAb DREG 55 and blocked with 2% BSA in PBS. Samples of each cell line were washed and resuspended to 1 ϫ 10 7 cells/ml in RPMI 1640 and 10% FBS. Immediately thereafter, 100 l medium containing 10 Ϫ5 M PMA and 10% DMSO was added to 900 l cell suspension. Medium with DMSO alone was added to control samples. Cells were stimulated for 15 min at 37°C and then pelleted. Supernatants were added to triplicate wells of mAb DREG-55-coated plates (30 min at 37°C). After washing three times, plates were incubated with biotinylated DREG-200 (1 g/ml). Streptavidin-coupled HRP and ABTS were added for development. Plates were incubated at room temperature for 15 min and read at 414 nm in a Titer-Tek Multiscan ELISA plate reader (Flow Laboratories, McLean, VA). Each assay included a serial dilution of a standard human serum sample containing 1.6 g/ml sL-selectin (gift from Dr. T. K. Kishimoto, Boehringer Ingelheim) to generate a standard curve. OD 414 measurements from supernatants of non-activated transfectants were subtracted from those of activated cells, and the resulting value was converted into activation-induced ectodomain protein concentration. To correlate the amount of sL-selectin in supernatant to the loss of surface-expressed protein, aliquots of the same samples of activated and nonactivated cells were simultaneously analyzed by flow cytometry to assess the mean number of shed ectodomains per cell as described above.
Inhibition of zinc-based metalloproteases
The hydroxamate-based metalloprotease inhibitor KD-IX-73-4 was diluted in DMSO as a 10 mg/ml stock solution. For experiments, the inhibitor was used at a final concentration of 50 g/ml (35) . Duplicate aliquots of each transfected cell line were either kept with the inhibitor or with an equivalent amount of DMSO and treated as follows: 1) no activation, 2) PMA activation (10 Ϫ6 M, 15 min), 3) activation in the presence of KD-IX-73-4, or 4) activation in the presence of KD-IX-73-4 followed by three washes and renewed exposure to PMA. All samples were analyzed by flow cytometry as described above.
Calmodulin inhibition
Cells were washed, resuspended to 10 6 /ml, and prestained with CFSE DREG-200 F(ab). TFP was diluted in DMSO as a 20-mM stock solution. For experiments, TFP was serially diluted and combined with cell samples to final concentrations of 25, 50, 75, and 100 M. Aliquots of each cell line were incubated with TFP or with an equivalent amount of DMSO for 15 min at 37°C and then fixed. A second set of cells was treated with TFP in the presence of KD-IX-73-4 (50 g/ml). Cells were analyzed by flow cytometry as described above.
Results
We have previously described a panel of stably transfected murine L1-2 pre-B cell lines that express the ectodomain of human Lselectin linked to the predicted TM/IC segment of WT L-selectin or CD44 or CD31 (14, 15) . The different subsurface segments target ectodomains either to microvilli (WT) or the planar cell body (L/CD44) or cause a random distribution (L/CD31). These different topographies markedly affect the cells' ability to engage with L-selectin ligands under conditions of flow, but they have no measurable impact on L-selectin-mediated rolling velocity after the cells have become tethered (14, 15) . Because the velocity of L-selectin-mediated rolling is partly determined by proteolytic cleavage of the ectodomain (41, 42) , the possibility remained that topographic effects on rolling velocity may have been masked by differential shedding. Moreover, it has not been determined whether L-selectin shedding requires any elements within the native TM/IC domain of L-selectin. To address these questions, shedding was induced by exposure of L1-2 cells to PMA, a potent activator of PKC. Previous studies have shown that PKC activation by PMA is an effective stimulus for L-selectin shedding for both primary leukocytes (28) and transfected cell lines, including the L1-2 cells used here (33) (U. H. von Andrian, unpublished observations).
PMA induces dose-dependent shedding of L-selectin ectodomains from L1-2 cells independent of TM/IC domains
Flow cytometric analysis of anti-human L-selectin mAb DREG-200 binding confirmed that L1-2 vector cells exhibit very low fluorescence that was not different from cells stained with a nonbinding control mAb and remained unchanged after exposure to PMA (data not shown). Therefore, L1-2 vector cells were used as a negative control to assess background fluorescence. Subclones of WT L-selectin, L/CD44, and L/CD31 transfectants were selected that expressed reproducibly high levels of L-selectin ectodomains. In all cases, ectodomains disappeared from the cell surface upon exposure to 10 Ϫ6 M PMA for 15 min (Table I and Fig. 1A) . Similar results were obtained with multiple subclones of each transfected cell line as well as with the parental polyclonal populations (not shown). Thus, it seems unlikely that the results described below were due to unique properties of individual subclones. At the relatively high PMA concentration chosen initially, all transfectants consistently lost Ͼ70% of their L-selectin ectodomains, indicating that TM/IC domains, and hence topography, are not essential to the shedding process. However, this finding alone did not exclude a more subtle role for the TM/IC domains that might affect the kinetics or sensitivity to submaximal stimulation. Therefore, we performed additional experiments to address this question.
To determine whether TM/IC domains affect the sensitivity of ectodomain shedding to mild stimulation, WT L-selectin, L/CD44, and L/CD31 transfectants were activated with serial dilutions of PMA. Ectodomain shedding was apparent in all three cell lines after exposure to PMA at concentrations as low as 2 ϫ 10 Ϫ9 M (Fig. 1B) . L-selectin down-regulation reached a maximum in each cell line at 4 ϫ 10 Ϫ8 M.
Similar kinetics of L-selectin down-regulation after PMA activation
To investigate the kinetics of PMA-induced down-regulation of L-selectin ectodomains, we exposed each of the three transfectants to PMA (10 Ϫ6 M) and stopped further activation at various time points by rapid fixation in ice-cold buffer. Fig. 2 shows the time course of L-selectin down-regulation as evidenced by the loss of mAb DREG-200 binding sites. All cell lines lost Ͼ50% of their L-selectin ectodomains within 5 min. At 10 min after addition of PMA nearly 80% of surface-expressed mAb DREG-200 binding sites had been lost, on the average. Somewhat slower kinetics of shedding were observed in WT transfectants than in the two chimera transfectants. This was probably due to the fact that WT transfectants expressed fewer ectodomains before activation, which may have resulted in more limited availability of substrate for the enzyme(s) mediating proteolytic cleavage (Table I) . Consistent with this idea, the time required for half-maximum ectodomain shedding was similar for each cell line (2.8 min for L/CD31, 3 min for L/CD44, and 3.8 min for WT L-selectin transfectants).
WT and chimeric L-selectin ectodomains are released into the culture supernatant
Having determined that all three transfectants lost surface-expressed L-selectin epitopes with equivalent sensitivity and similar kinetics upon activation, we asked whether this effect involved the same mechanism(s). To test whether ectodomains were shed by proteolytic cleavage, we measured sL-selectin in supernatants of activated and nonactivated transfectants using an ELISA (32) . Atthe same time, the average number of shed L-selectin ectodomains was determined by FACS analysis of cell aliquots before and after vector cells as ϳ4.0 using a logarithmic acquisition scale. DREG-200 binding sites were determined using a standardized microbead system (Quantum Simply Cellular). Data are shown as mean Ϯ SEM of three independent experiments. activation. A significant increase in sL-selectin concentrations was found in the supernatants of all three transfectants upon PMA activation (Fig. 3) . There was a significant positive correlation of sL-selectin concentrations determined by ELISA and L-selectin ectodomain down-regulation assessed by flow cytometry, indicating that the activation-induced loss of L-selectin epitopes from the cell surface was in each case due to release of ectodomains and not to other mechanisms, such as internalization or masking of surface epitopes.
Shedding of WT and chimeric L-selectin ectodomains is blocked by KD-IX-73-4, an inhibitor of zinc-based metalloproteases
To determine whether the mechanisms of ectodomain shedding are similar for WT and chimeric molecules, each transfectant was activated in the presence of the metalloprotease inhibitor KD-IX-73-4 (50 g/ml). Consistent with previous reports (35, 39, 41) , KD-IX-73-4 was highly efficient in blocking shedding of WT Lselectin (Fig. 4) . Importantly, KD-IX-73-4 was equally potent in preventing PMA-induced shedding from L/CD44 and L/CD31 transfectants. Without PMA, inhibitor-treated cells showed slightly elevated ectodomain expression compared with untreated cells, perhaps due to inhibition by KD-IX-73-4 of a low constitutive sheddase activity in L1-2 cells. Down-regulation of L-selectin ectodomains following cell activation with PMA was restored after KD-IX-73-4 was thoroughly washed away, indicating that KD-IX-73-4 did not irreversibly alter cell function.
Inhibition of calmodulin induces L-selectin ectodomain shedding that is partially independent of the TM/IC domain
Calmodulin, an intracellular calcium regulatory protein, has been previously shown to bind directly to the IC domain of L-selectin (39) . Calmodulin inhibitors, such as TFP, induce proteolytic shedding of L-selectin without causing cell activation (39) . One possible mechanism for this observation may be that calmodulin binding to the IC domain protects the ectodomain from proteolytic cleavage. Alternatively, calmodulin inhibition might induce shedding independent of its interaction with the IC domain of L-selectin. To address this question, we treated L1-2 transfectants with various concentrations of TFP. Shedding among cells containing differing TM/IC domains was readily detectable and occurred to a similar degree ( p Ͻ 0.05 vs sham treated) upon exposure to 50 M TFP (Fig. 5) . In contrast, at higher TFP concentrations (75 and 100 M), WT L-selectin shedding was significantly more complete FIGURE 3. sL-selectin in supernatant correlates with PMA-induced Lselectin ectodomain down-regulation on WT L-selectin, L/CD44, and L/CD31 transfectants. Multiple transfected subclones expressing different baseline levels of WT and chimeric L-selectin (each identified by a different symbol) were maximally stimulated with PMA and sL-selectin was quantified in the supernatant using an ELISA as described in Materials and Methods. An sL-selectin standard curve (based on a human serum standard) was used to determine the concentration of sL-selectin in supernatants after subtraction of background levels from nonactivated samples. The average number of down-regulated L-selectin ectodomains per cell was determined by concurrent FACS analysis. than that of the chimeras. In the presence of KD-IX-73-4, calmodulin inhibition by TFP did not induce significant shedding in any cell line, suggesting that the proteolytic mechanism(s) of L-selectin down-regulation by TFP was closely related to or identical with that induced by PMA.
Shedding occurs without redistribution of ectodomains following PMA activation
Although the data presented above clearly show that TM/IC domains are not relevant for PMA-or TFP-induced ectodomain shedding, this does not prove unequivocally that L-selectin topography is also irrelevant for this process. Even though ectodomain distribution is determined by TM/IC domains on resting cells (14, 15) , it remained theoretically possible that the activating stimuli caused a redistribution of L-selectin on the cell surface independent of TM/IC domains. To address this possibility, we investigated the distribution of colloidal-gold labeled anti-L-selectin Abs on each transfectant before and during the activation process. Cells were exposed to PMA (10 Ϫ6 M) for 0, 1, and 3 min, fixed, washed, and immunogold labeled for LVSEM analysis. Because activated cells quickly lost L-selectin (Fig. 2) , relatively few gold particles could be detected on cells that were exposed to PMA for 3 min or longer. Therefore, some cells were activated in the presence of KD-IX-73-4, which allowed us to determine the topography of WT and chimeric molecules at all time points.
We noted that upon PMA activation, either with or without protease inhibition, cells underwent striking morphological changes. Microvilli appeared to retract, while ridge-like structures took form, seemingly replacing most of the finger-like microvilli that were typically seen on resting cells (Fig. 6) . Gold particles were quantified and assigned to one of three different surface domains based on the following criteria. Membrane projections were separated into halves. The top half was defined as the tip and the distal 50% of the microvilli, or peak of any ridge, or other detectable projection/protrusion from the cell surface. The lower half was defined as the surface area from the base of a projection to the border of the top half. Gold particles were assigned to the cell body when they were not detectably associated with a surface projection. As previously described, WT L-selectin ectodomains were expressed preferentially on the tips of microvilli. In contrast, cells transfected with the L/CD44 chimera displayed L-selectin ectodomains preferentially on the cell body (14) . The ectodomains on cells expressing L/CD31 chimera were randomly distributed; half were found on the cell body, whereas the remainder were almost evenly split between the top and bottom halves of the microvilli.
Of note, the distribution of all ectodomains remained essentially unaltered upon activation (Figs. 7 and 8) . Thus, L-selectin shedding can occur in all parts of the cell surface and does not require redistribution of ectodomains before rapid and efficient cleavage ensues.
Discussion
Here we have examined the role of the TM/IC domain of L-selectin during activation-induced shedding. Using stably transfected L1-2 cells expressing WT or chimeric L-selectin with different subsurface components and different surface distribution patterns (14, 15) , we show that the ectodomain alone is sufficient for normal PMA-induced proteolytic cleavage by one or more hydroxamate-sensitive proteases.
Although many surface molecules can be shed by leukocytes in response to a variety of stimuli (43) (44) (45) , L-selectin shedding is unusual in that it occurs extremely rapidly and with marked efficacy. Previous work has demonstrated that L-selectin shedding is triggered by many diverse stimuli. Some of the many sheddinginducing signals include numerous inflammatory cytokines and chemoattractants (27) , most of which signal through G proteincoupled receptors and induce PKC activation (46); extracellular ATP (47); C-reactive protein (48); cross-linking of ␤ 2 integrins (49) or of the L-selectin ectodomain itself (50, 51) ; and a number of pharmacologic reagents that activate PKC directly (52), act as inhibitors of calmodulin (39), or possess thiol-oxidizing or -blocking activity (53) . In addition, upon activation of T cells by Ag, L-selectin expression is down-modulated by reduced transcription of the L-selectin gene (52, 54) .
L-selectin shedding has also been observed in several settings in vivo. For example, neutrophils shed L-selectin before or during transendothelial migration in inflamed lung tissue (55) . Painful stimuli can also induce L-selectin shedding from circulating neutrophils, which resulted in reduced neutrophil migration into inflamed joints and improved clinical symptoms in a rat arthritis model (56) . In this situation, shedding was thus beneficial by limiting tissue inflammation. The anti-inflammatory effects of glucocorticosteroids and nonsteroidal anti-inflammatory drugs may also be due in part to induction of L-selectin shedding (57, 58) . However, in some pathologic conditions, such as septicemia, excessive L-selectin shedding from circulating neutrophils may contribute to dysfunctional neutrophil migration (59, 60) . Similarly, systemic treatment of mice with bacterial superantigens induced a rapid loss of L-selectin from reactive T cells (61) .
The shed ectodomain, sL-selectin, is readily detectable in normal human serum and exerts anti-adhesive effects at concentrations above ϳ10 g/ml (62). Up to 2 mg/ml of sL-selectin has been reported in serum of patients with myeloproliferative disorders and certain lymphomas (63, 64) . Thus, even though the physiologic role of L-selectin shedding is still controversial, there are numerous clinical settings where this phenomenon may either serve as a protective feedback mechanism or exacerbate existing pathologies. For these reasons, it is important to develop a thorough understanding of the cellular and molecular mechanisms that regulate this process.
The L-selectin sheddase has not been identified. As mentioned above, TACE-deficient thymocytes do not lose L-selectin when stimulated with PMA (37) . Interestingly, TACE has a punctate distribution on human leukocytes (38) indicating that it, like Lselectin (25) , is not homogeneously expressed over the entire cell circumference. However, it is not known whether TACE mediates L-selectin shedding from mature leukocytes. Another study has suggested that a protein disulfide isomerase may be involved (53). Nevertheless, given the conspicuous distribution of TACE and considering the rapidity at which shedding occurs on normal leukocytes (6) as well as L1-2 transfectants (this report), it seemed reasonable to speculate that the L-selectin sheddase and/or molecules that regulate its activity might be targeted to the same surface domain as WT L-selectin, i.e., to microvilli. We surmised that if such a topographic association played a role, there should be detectable differences between the kinetics and/or sensitivity at which differentially distributed ectodomains are shed from L1-2 transfectants.
Contrary to our expectations, a particular surface topography is clearly not required for L-selectin shedding to occur, at least in response to PKC activation. Regardless of ectodomain distribution, the magnitude and kinetics of PMA-induced shedding were equivalent in all transfected cell lines. Moreover, PMA-mediated activation of cells in suspension did not induce a significant redistribution of the transfected molecules. This was important to rule out, because a previous study had shown that both L-selectin and CD44 can undergo capping upon extensive cross-linking, and both are redistributed to pseudopodia on migrating lymphocytes (65) . Moreover, full-length CD31 has been localized preferentially to cell-cell junctions in endothelial monolayers and a variety of transfected cell lines (66) . Although these distribution patterns of CD31 and CD44 are probably controlled by interactions that require their respective ectodomains, effects of activating signals on cytoskeletal interactions with TM/IC domains cannot be ruled out. For example, if PMA made the topography of chimeric molecules more similar to that of WT L-selectin, this could afford a closer proximity to the sheddase. However, our LVSEM analysis found no evidence for ectodomain redistribution during the first 3 min of PMA activation when most ectodomains are shed, even though the appearance of surface projections changed markedly during that time interval.
Several studies have used metalloprotease inhibitors to address the physiologic role of L-selectin shedding (34, 35, 41, 42, 67, 68) . The results of these experiments vary significantly and appear to depend on the assay system. Flow chamber studies that have examined L-selectin-dependent interactions with endothelial monolayers failed to detect effects on neutrophil adhesion by shedding inhibitors (67) . In contrast, in vitro studies using immobilized Lselectin ligands in a similar assay showed that neutrophil rolling velocity was markedly reduced in the presence of KD-IX-74-3 (41). More recently, in vivo studies with another hydroxamatebased inhibitor of L-selectin shedding reported significant slowing of rolling and enhanced accumulation of leukocytes in cytokinetreated cremaster muscle venules (42, 69) . These discrepancies between different experimental models of shedding inhibition remain unresolved.
Nevertheless, the data reported here shed further light on previous in vivo studies with L1-2 transfectants with different L-selectin ectodomain topographies. We have demonstrated that the topographic distribution of ectodomains plays an important role during the initiation of adhesive contact (tethering), whereas subsequent established rolling interactions, such as rolling velocity and jerkiness of rolling, were not different between cell lines (15) . This finding contradicted theoretical models of selectin-mediated rolling that had postulated that microvilli properties control the character of rolling (70, 71) . To explain this discrepancy, we proposed that microvilli may be flexed or disappear in the contact zone between rolling leukocytes and the endothelium, possibly aided by constant collisions with fast flowing RBC (15) . However, as discussed above, some studies have found that inhibition of L-selectin shedding reduces rolling velocity (41, 42) . Thus, the possibility remained that differential shedding of ectodomains could have obscured more subtle differences in adhesive behavior due to ectodomain topography. The present data make it clear that the differential tethering ability of our transfectants cannot be explained by differences in shedding, nor is it likely that differential shedding during rolling could have masked subtle topography-dependent differences in rolling velocity or jerkiness.
Our data also reveal a complex relationship between PKC, calmodulin, L-selectin, and the L-selectin sheddase(s). Previous work has shown that calmodulin can associate with the juxtamembrane region in the cytoplasmic tail of L-selectin and that calmodulin inhibitors such as TFP induce shedding (39, 72) . Because calmodulin and PKC are thought to obstruct each other's function (73) , it seems plausible that PKC agonists may exert their effects by deactivating a poorly understood process by which calmodulin protects L-selectin from proteolytic cleavage. However, it has been unclear whether calmodulin is essential in PKC-induced shedding and to what extent calmodulin interactions with L-selectin are linked to its role in this event.
The present experiments show that both chimeric and WT Lselectin transfectants shed L-selectin similarly upon exposure to 50 M TFP, but this effect was much less complete than the near total loss of surface-expressed ectodomains that was observed after maximal PKC activation. Using high doses of TFP, we observed a similarly dramatic loss of L-selectin expression only in WT transfectants, whereas a substantial fraction of chimeric molecules were not cleaved at TFP doses up to 100 M (higher doses exerted toxic effects on L1-2 cells and, therefore, could not be tested). This suggests that calmodulin may regulate L-selectin sheddase activity through two distinct modes. One pathway may be more sensitive to TFP inhibition and is independent of calmodulin interactions with the TM/IC domain of L-selectin. This idea is consistent with recent studies on calmodulin inhibitor-mediated cleavage of other membrane proteins, such as the receptor tyrosine kinase TrkA, which was shed even after the intracellular calmodulin binding site of TrkA was mutated or deleted (72) . In addition, a second pathway that is only triggered by relatively high doses of TFP appears to control shedding of a subpopulation of L-selectin molecules in a fashion that requires the WT TM/IC domain. Because this region is absent in L/CD44 and L/CD31, ectodomains are only partially shed when the chimera transfectants are exposed to TFP. However, this high dose TFP-sensitive calmodulin pathway does not appear to play a role during PKC-induced shedding, because PMA had nearly complete and equivalent effects on all transfectants in every treatment modality tested. Thus, it seems likely that PKC activates the L-selectin sheddase(s) through signaling pathways that are at least in part independent of calmodulin inhibition.
Taken together, the results of this study demonstrate that the ectodomain of L-selectin alone is sufficient for normal PMA-induced proteolytic cleavage by one or more hydroxamate-sensitive proteases. Because microvillous WT L-selectin, cell body-expressed L/CD44, and randomly distributed L/CD31 were cleaved with equivalent sensitivity and kinetics and were not redistributed on the surface of activated cells in suspension, we conclude that the sheddase(s) appears to have equal access and activity on all aspects of the leukocyte surface. Subtle differences in transfectant responses to calmodulin inhibition raise the possibility that calmodulin influences L-selectin shedding through two distinct pathways, one requiring interactions with the cytoplasmic tail of Lselectin, and the other independent of such intracellular interactions.
